Live tape
Top 8, mentions 7d12,383TSLA2,987 mentions▲ +0.05SPCX2,488 mentions▲ +0.08GOOGL1,620 mentions▲ +0.03META1,411 mentions▲ +0.05CRWV984 mentions▲ +0.04NVDA981 mentions▲ +0.07QQQ962 mentions▲ +0.05NFLX950 mentions▲ +0.03

Equity · Healthcare

CNMD

NYSE

Conmed (CNMD)

$48 +4.35% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 20, 2026
Price · Chart
31 sessions
$50 $42 24 Jul 20 Oct

The line runs $43 on 24 July through $48 on 20 October, on a scale from $42 to $50. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 31 sessions, 24 Jul – 20 Oct 2026
Market cap $1.4B
P/E (TTM) 31.8
52-week range $32 – $49
Avg volume 30.4K

as of Oct 20, 2026

Conmed (CNMD) insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 8 Sep 2026

In the 90 days to 22 Oct 2026, no Conmed insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4).

Open-market buys 0
Open-market sells 0
Non-trade filings 1

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
08 Sep 2026 Kelderman Kim Director Option exercise 500

Conmed (CNMD) reported financials

SEC EDGAR XBRL SEC EDGAR

Conmed reported revenue of $1.4B for the fiscal year ended 31 Dec 2025. Net income over the same period was $47.1M.

Figure Reported Period
Revenue $1.4B 31 Dec 2025 fiscal year
Net income $47.1M 31 Dec 2025 fiscal year
Diluted EPS $1.51 31 Dec 2025 fiscal year
Total assets $2.3B 30 Jun 2026 at period end
Total equity $1.0B 30 Jun 2026 at period end

Conmed (CNMD) earnings

SEC EDGAR

Conmed last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.77; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.77 $343M
31 Dec 2025 FY 2025 $1.51 $1.37B
30 Sep 2025 Q3 2025 $0.09 $338M
30 Jun 2025 Q2 2025 $0.69 $342M
31 Mar 2025 Q1 2025 $0.19 $321M
31 Dec 2024 FY 2024 $4.25 $1.31B
30 Sep 2024 Q3 2024 $1.57 $317M
30 Jun 2024 Q2 2024 $0.96 $332M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Conmed (CNMD) institutional holders (13F)

SEC Form 13F SEC EDGAR

9 of the 45 institutional funds we track reported a Conmed position for the quarter ended 30 Jun 2026 — a combined $54.3M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Two Sigma Investments Held (±25%) −6.8% shares 728,976 $23.9M
AQR Capital Management Added +250.1% shares 280,916 $9.2M
Marshall Wace Held (±25%) +2.8% shares 175,454 $5.7M
Citadel Advisors Trimmed −42.4% shares 142,263 $4.7M
Millennium Management Added +51.0% shares 114,609 $3.8M
Point72 Asset Management Trimmed −48.1% shares 69,585 $2.3M
D. E. Shaw & Co. Added +42.4% shares 68,134 $2.2M
GAMCO Investors Held (±25%) 57,200 $1.9M
Tudor Investment Corp New position 23,303 $763K
Balyasny Asset Management Exited

Conmed (CNMD) fails-to-deliver

SEC CNS data SEC

On 30 Sep 2026, 658 shares of Conmed failed to deliver (about $31K).

Settlement date Shares failed Notional % of shares out
30 Sep 2026 658 $31K 0.002%
21 Sep 2026 24 $1K <0.001%
18 Sep 2026 3 $138 <0.001%
10 Sep 2026 3,268 $153K 0.011%

Congressional trades in Conmed (CNMD)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Conmed is a purchase by David J. Taylor (house, OH), dated 15 Feb 2019.

Date Member Type Amount
15 Feb 2019 filed 14 Mar 2019 David J. Taylor house · Republican–OH Purchase $1K–$15K

Conmed (CNMD): frequently asked questions

From live data

Have Conmed insiders bought or sold shares recently?

In the 90 days to 22 Oct 2026, no Conmed insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4).

How many institutions hold Conmed?

9 of the 45 institutional funds we track reported a Conmed position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Conmed had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Conmed is dated 30 Sep 2026, when 658 shares failed to deliver.

When did Conmed last report earnings?

Conmed last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.77; no next date is announced in SEC filings yet.

What exchange is Conmed listed on?

Conmed trades on NYSE under the ticker CNMD.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings